Moreover, despite the effects on glucose uptake, GLUT3 upregulation enhances the ability of primary brain cancer cells to resist certain chemotherapy drugs that could inhibit cancer cell angiogenesis [15]. This evidence concerns the gene SLC2A3 and brain cancer.